Indication
Generalized vaccinia
Generalized vaccinia is an uncommon systemic complication of smallpox vaccination characterized by widespread cutaneous dissemination of the live vaccinia virus, most frequently occurring in primary vaccine recipients. Read more about Generalized vaccinia
1 drugs 1 manufacturers
Drugs that treat it
Common Generalized vaccinia therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGeneralized vaccinia is an uncommon systemic complication of smallpox vaccination characterized by widespread cutaneous dissemination of the live vaccinia virus, most frequently occurring in primary vaccine recipients.
Pathophysiologically, the condition results from transient hematogenous dissemination (viremia) from the primary inoculation site rather than accidental autoinoculation.
Clinically, it manifests six to nine days post-vaccination as a generalized maculopapular, vesicular, or pustular rash on normal skin, often accompanied by systemic symptoms such as fever, malaise, and headache.
While generalized vaccinia is typically benign and self-limiting in immunocompetent individuals, it can present with a severe or protracted course in patients with underlying immunodeficiency.
- cdc.gov
Generalized vaccinia is an uncommon systemic complication of smallpox vaccination characterized by widespread cutaneous dissemination of the live vaccinia virus, most frequently occurring in primary vaccine recipients Clinically, it manifests six to nine days post-vaccination as a generalized maculopapular, vesicular, or pustular rash on normal skin, often accompanied by systemic symptoms such as fever, malaise, and headache While generalized vaccinia is typically benign and self-limiting in imm...
- azdhs.gov
Generalized vaccinia is an uncommon systemic complication of smallpox vaccination characterized by widespread cutaneous dissemination of the live vaccinia virus, most frequently occurring in primary vaccine recipients Clinically, it manifests six to nine days post-vaccination as a generalized maculopapular, vesicular, or pustular rash on normal skin, often accompanied by systemic symptoms such as fever, malaise, and headache While generalized vaccinia is typically benign and self-limiting in imm...
- nih.gov
Pathophysiologically, the condition results from transient hematogenous dissemination (viremia) from the primary inoculation site rather than accidental autoinoculation
- natap.org
Pathophysiologically, the condition results from transient hematogenous dissemination (viremia) from the primary inoculation site rather than accidental autoinoculation
- cdc.gov
Clinically, it manifests six to nine days post-vaccination as a generalized maculopapular, vesicular, or pustular rash on normal skin, often accompanied by systemic symptoms such as fever, malaise, and headache
Personalize your experience
Follow Generalized vaccinia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.